【癌症】《Zephyr AI》開發新型AI複合生物標記，預測末期癌症對「PARP抑制劑」的敏感性

 【癌症】《Zephyr AI》開發新型AI複合生物標記，可有效預測晚期癌症患者對「PARP抑制劑」的敏感性

 文章出處  

Businesswire 

 

 原文標題  

Zephyr AI Presents the Development of a Novel AI-Enabled Composite Biomarker Effective in Predicting Sensitivity to PARP Inhibition in Late-line Cancer Patients 

 

 Twitter  

https://x.com/aimedadviser/status/1798498459173212359 

 

 文章序號  

5716 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2024 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.